New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 28, 2014
08:10 EDTCGOrtho-Clinical Diagnostics, Astute Medical to develope acute kidney injury tests
Ortho-Clinical Diagnostics announced it has entered into a strategic partnership with Astute Medical, under which OCD will become the exclusive commercial partner for the distribution of Astute’s NEPHROCHECK Test and ASTUTE140 Meter in certain markets in Europe and, pending FDA clearance, the United States. On June 30, OCD became an independent, stand-alone diagnostics company with a renewed commitment to expand market reach with differentiated platforms and menus to better serve lab customers. Under the agreement, OCD also receives a semi-exclusive license to develop, manufacture and sell the NEPHROCHECK Test for use on its VITROS line of automated, high-volume testing platforms. In addition, as part of this strategic agreement, OCD has made a $15M equity investment in Astute Medical. Astute will be responsible for manufacturing the Astute NEPHROCHECK Test for use on the ASTUTE140 Meter in all markets and will collaborate with OCD on the sale of the NEPHROCHECK Test.
News For CG From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 24, 2015
15:07 EDTCGCarlyle, Cap Gemini talks to buy CSC have 'fizzled,' Reuters says
Consulting company Cap Gemini and private equity firm Carlyle Group (CG) previously held talks about a potential acquisition of Computer Sciences Corp. (CSC), though the talks have since "fizzled," reported Reuters, citing people familiar with the matter. CSC is now working with Royal Bank of Canada (RY) to review its options, the report added. Reference Link
14:56 EDTCGCarlyle, Cap Gemini talks to buy CSC have 'fizzled,' Reuters says
Subscribe for More Information
February 23, 2015
13:49 EDTCGCarlyle Group, Advent mull sale of H.C. Starck, Bloomberg reports
Subscribe for More Information
February 18, 2015
10:05 EDTCGOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Agnico Eagle (AEM) upgraded to Overweight from Neutral at JPMorgan... Amarin (AMRN) upgraded to Buy from Neutral at SunTrust... Capital Product (CPLP) upgraded to Accumulate from Neutral at Global Hunter... Carlyle Group (CG) upgraded to Buy from Neutral at Citigroup... Danone (DANOY) upgraded to Neutral from Underperform at Exane BNP Paribas... Express (EXPR) upgraded on lower promotional activity at Piper Jaffray... Kforce (KFRC) upgraded to Outperform from Market Perform at Avondale... Legg Mason (LM) upgraded to Buy from Hold at Jefferies... Rackspace (RAX) upgraded following Q4 results at Pacific Crest... Rosetta Resources (ROSE) upgraded to Buy from Neutral at Global Hunter... SeaChange (SEAC) upgraded to Buy from Hold at Noble Financial... Valero (VLO) upgraded to Outperform from Neutral at Credit Suisse... Veeco (VECO) upgraded to Buy from Hold at Noble Financial... Wolverine World Wide (WWW) upgraded to Neutral from Underperform at Sterne Agee.
06:08 EDTCGCarlyle Group upgraded to Buy from Neutral at Citigroup
Citigroup upgraded Carlyle Group to Buy saying it believes the company is entering a "robust" harvesting cycle. Citi says Carlyle is at a favorable inflection point and raised its price target for the stock to $32 from $30.50.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use